Home >> Materials & Chemicals >> Consumer Goods >>

Global Hospital-Acquired Infection Control Market Research Report 2018

Published: Sep-2018 | Format: PDF | BisReport | Number of pages: 124 | Code: MRS - 319773

Global Hospital-Acquired Infection Control Market Report 2018 
 
 
With the slowdown in world economic growth, the Hospital-Acquired Infection Control industry 
has also suffered a certain impact, but still maintained a relatively optimistic growth, the past 
four years, Hospital-Acquired Infection Control market size to maintain the average annual 
growth rate of 7.19% from 626 million $ in 2014 to 771 million $ in 2017,
believe that in the next few years, Hospital-Acquired Infection Control market size will be further 
expanded, we expect that by 2022, The market size of the Hospital-Acquired Infection Control 
will reach 1050 million $.  
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, 
interview record, business distribution etc., these data help the consumer know about the 
competitors better. This report also covers all the regions and countries of the world, which 
shows a regional development status, including market size, volume and value, as well as price 
data. 
Besides, the report also covers segment data, including: type segment, industry segment, 
channel segment etc. cover different segment market size, both volume and value. Also cover 
different industries clients information, which is very important for the manufacturers.

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
AstraZeneca 
GlaxoSmithKline 
Merck 
Pfizer 
3M 
Abbott Laboratories 
AbbVie 
Advanced Sterilization Products 
Alere 
Bayer 
BD 
BioMérieux 
Cepheid 
Getinge Group 
Hoffmann La-Roche 
Synergy Health 
Xenex 
 
Region Segmentation 
North America Country (United States, Canada) 
South America 
Asia Country (China, Japan, India, Korea) 
Europe Country (Germany, UK, France, Italy) 
Other Country (Middle East, Africa, GCC) 
 
Product Type Segmentation 
Catheter-associated urinary tract infections (CAUTIs) 
Surgical site infections (SSIs) 
Central line-associated bloodstream infections (CLABSIs) 
Respiratory infections 
 
Industry Segmentation 
Hospitals and ICUs 
Outpatient care centers 
Long-term care facilities (LTCFs) 
 
Channel Segmentation 
Direct Sales 
Distributor 

 
Table of Contents 
Section 1 Hospital-Acquired Infection Control Product Definition 
 
Section 2 Global Hospital-Acquired Infection Control Market Manufacturer Share and Market 
Overview 
2.1 Global Manufacturer Hospital-Acquired Infection Control Shipments 
2.2 Global Manufacturer Hospital-Acquired Infection Control Business Revenue 
2.3 Global Hospital-Acquired Infection Control Market Overview 
 
Section 3 Manufacturer Hospital-Acquired Infection Control Business Introduction 
3.1 AstraZeneca Hospital-Acquired Infection Control Business Introduction 
3.1.1 AstraZeneca Hospital-Acquired Infection Control Shipments, Price, Revenue and Gross 
profit 2014-2017 
3.1.2 AstraZeneca Hospital-Acquired Infection Control Business Distribution by Region 
3.1.3 AstraZeneca Interview Record 
3.1.4 AstraZeneca Hospital-Acquired Infection Control Business Profile 
3.1.5 AstraZeneca Hospital-Acquired Infection Control Product Specification 
 
3.2 GlaxoSmithKline Hospital-Acquired Infection Control Business Introduction 
3.2.1 GlaxoSmithKline Hospital-Acquired Infection Control Shipments, Price, Revenue and Gross 
profit 2014-2017 
3.2.2 GlaxoSmithKline Hospital-Acquired Infection Control Business Distribution by Region 
3.2.3 Interview Record 
3.2.4 GlaxoSmithKline Hospital-Acquired Infection Control Business Overview 
3.2.5 GlaxoSmithKline Hospital-Acquired Infection Control Product Specification 
 
3.3 Merck Hospital-Acquired Infection Control Business Introduction 
3.3.1 Merck Hospital-Acquired Infection Control Shipments, Price, Revenue and Gross profit 
2014-2017 
3.3.2 Merck Hospital-Acquired Infection Control Business Distribution by Region 
3.3.3 Interview Record 
3.3.4 Merck Hospital-Acquired Infection Control Business Overview 
3.3.5 Merck Hospital-Acquired Infection Control Product Specification 
 
3.4 Pfizer Hospital-Acquired Infection Control Business Introduction 
3.5 3M Hospital-Acquired Infection Control Business Introduction 
3.6 Abbott Laboratories Hospital-Acquired Infection Control Business Introduction 
… 
 
Section 4 Global Hospital-Acquired Infection Control Market Segmentation (Region Level) 
4.1 North America Country 
4.1.1 United States Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.1.2 Canada Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.2 South America Country 
4.2.1 South America Hospital-Acquired Infection Control Market Size and Price Analysis 2014-
2017 
4.3 Asia Country 
4.3.1 China Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.3.2 Japan Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.3.3 India Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.3.4 Korea Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.4 Europe Country 
4.4.1 Germany Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.4.2 UK Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.4.3 France Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.4.4 Italy Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.4.5 Europe Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.5 Other Country and Region 
4.5.1 Middle East Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.5.2 Africa Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.5.3 GCC Hospital-Acquired Infection Control Market Size and Price Analysis 2014-2017 
4.6 Global Hospital-Acquired Infection Control Market Segmentation (Region Level) Analysis 
2014-2017 
4.7 Global Hospital-Acquired Infection Control Market Segmentation (Region Level) Analysis 
 
Section 5 Global Hospital-Acquired Infection Control Market Segmentation (Product Type Level) 
5.1 Global Hospital-Acquired Infection Control Market Segmentation (Product Type Level) 
Market Size 2014-2017 
5.2 Different Hospital-Acquired Infection Control Product Type Price 2014-2017 
5.3 Global Hospital-Acquired Infection Control Market Segmentation (Product Type Level) 
Analysis 
 
Section 6 Global Hospital-Acquired Infection Control Market Segmentation (Industry Level) 
6.1 Global Hospital-Acquired Infection Control Market Segmentation (Industry Level) Market Size 
2014-2017 
6.2 Different Industry Price 2014-2017 
6.3 Global Hospital-Acquired Infection Control Market Segmentation (Industry Level) Analysis 
 
Section 7 Global Hospital-Acquired Infection Control Market Segmentation (Channel Level) 
7.1 Global Hospital-Acquired Infection Control Market Segmentation (Channel Level) Sales 
Volume and Share 2014-2017 
7.2 Global Hospital-Acquired Infection Control Market Segmentation (Channel Level) Analysis 
 
Section 8 Hospital-Acquired Infection Control Market Forecast 2018-2022 
8.1 Hospital-Acquired Infection Control Segmentation Market Forecast (Region Level) 
8.2 Hospital-Acquired Infection Control Segmentation Market Forecast (Product Type Level) 
8.3 Hospital-Acquired Infection Control Segmentation Market Forecast (Industry Level) 
8.4 Hospital-Acquired Infection Control Segmentation Market Forecast (Channel Level) 
 
Section 9 Hospital-Acquired Infection Control Segmentation Product Type 
9.1 Catheter-associated urinary tract infections (CAUTIs) Product Introduction 
9.2 Surgical site infections (SSIs) Product Introduction 
9.3 Central line-associated bloodstream infections (CLABSIs) Product Introduction 
9.4 Respiratory infections Product Introduction 
 
Section 10 Hospital-Acquired Infection Control Segmentation Industry 
10.1 Hospitals and ICUs Clients 
10.2 Outpatient care centers Clients 
10.3 Long-term care facilities (LTCFs) Clients 
 
Section 11 Hospital-Acquired Infection Control Cost of Production Analysis 
11.1 Raw Material Cost Analysis 
11.2 Technology Cost Analysis 
11.3 Labor Cost Analysis 
11.4 Cost Overview 
 
Section 12 Conclusion 
 
Chart and Figure 
Figure Hospital-Acquired Infection Control Product Picture from AstraZeneca 
Chart 2014-2017 Global Manufacturer Hospital-Acquired Infection Control Shipments (Units) 
Chart 2014-2017 Global Manufacturer Hospital-Acquired Infection Control Shipments Share 
Chart 2014-2017 Global Manufacturer Hospital-Acquired Infection Control Business Revenue 
(Million) 
Chart 2014-2017 Global Manufacturer Hospital-Acquired Infection Control Business Revenue 
Share 
Chart AstraZeneca Hospital-Acquired Infection Control Shipments, Price, Revenue and Gross 
profit 2014-2017 
Chart AstraZeneca Hospital-Acquired Infection Control Business Distribution 
Chart AstraZeneca Interview Record (Partly) 
Figure AstraZeneca Hospital-Acquired Infection Control Product Picture 
Chart AstraZeneca Hospital-Acquired Infection Control Business Profile 
Table AstraZeneca Hospital-Acquired Infection Control Product Specification 
Chart GlaxoSmithKline Hospital-Acquired Infection Control Shipments, Price, Revenue and Gross 
profit 2014-2017 
Chart GlaxoSmithKline Hospital-Acquired Infection Control Business Distribution 
Chart GlaxoSmithKline Interview Record (Partly) 
Figure GlaxoSmithKline Hospital-Acquired Infection Control Product Picture 
Chart GlaxoSmithKline Hospital-Acquired Infection Control Business Overview 
Table GlaxoSmithKline Hospital-Acquired Infection Control Product Specification 
Chart Merck Hospital-Acquired Infection Control Shipments, Price, Revenue and Gross profit 
2014-2017 
Chart Merck Hospital-Acquired Infection Control Business Distribution 
Chart Merck Interview Record (Partly) 
Figure Merck Hospital-Acquired Infection Control Product Picture 
Chart Merck Hospital-Acquired Infection Control Business Overview 
Table Merck Hospital-Acquired Infection Control Product Specification 
3.4 Pfizer Hospital-Acquired Infection Control Business Introduction 

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2350 View Pricing